发明名称 Compounds as lysophosphatidic acid receptor antagonists
摘要 Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
申请公布号 US9624182(B2) 申请公布日期 2017.04.18
申请号 US201514755383 申请日期 2015.06.30
申请人 AMIRA PHARMACEUTICALS, INC. 发明人 Seiders Thomas J.;Zhao Lucy;Arruda Jeannie;Wang Bowei;Stearns Brian Andrew;Truong Yen Pham;Scott Jill Melissa;Hutchinson John Howard;Clark Ryan;Coate Heather Renee;Stock Nicholas Simon;Volkots Deborah
分类号 C07D417/12;C07D413/06;C07D413/12;C07D495/04;C07D261/08;C07D261/14;A61K31/519;A61K31/4725;A61K31/4439;A61K31/427;A61K31/4709;C07D261/18;C07D405/12;A61K31/42;A61K31/422 主分类号 C07D417/12
代理机构 Hoffmann & Baron, LLP 代理人 Hoffmann & Baron, LLP
主权项 1. A compound with a structure of Formula (II), or a pharmaceutically acceptable solvate, a pharmaceutically acceptable salt, or a prodrug thereof: wherein m is 0 or 1; n is 0 or 1; L1 is absent, C1-C4alkylene, C1-C4fluoroalkylene, C3-C6cycloalkylene, —C3-C6cycloalkylene-C1-C4alkylene-, C1-C4alkylene-C3-C6cycloalkylene, or —C(R1a)(R1b)—; R1a and R1b are each independently selected from H, C1-C4alkyl and benzyl; R1 is —CO2RD, —C(═O)NHSO2RE, —C(═O)N(RD)2, or tetrazolyl; RD is H or C1-C6alkyl; RE is C1-C6alkyl or a substituted or unsubstituted phenyl; L3 is a substituted or unsubstituted C1-C6alkylene, substituted or unsubstituted C1-C6fluoroalkylene, or substituted or unsubstituted C1-C6heteroalkylene, where if L3 is substituted then L3 is substituted with 1, 2 or 3 R13; each R13 is independently selected from F, C1-C4alkyl, C1-C4fluoroalkyl, hydroxyl, C1-C4alkoxy, C1-C4fluoroalkoxy and a substituted or unsubstituted phenyl; or L3 is -L4-X1-L5-; L4 is absent or a substituted or unsubstituted C1-C4alkylene, where if L4 is substituted then L4 is substituted with 1, 2, or 3 R14; each R14 is independently selected from F, C1-C4alkyl, C1-C4fluoroalkyl, hydroxyl, C1-C4alkoxy and C1-C4fluoroalkoxy; X1 is a absent, —O—, —S—, —S(O)—, —S(O)2—, —NR7—, —C(O)NR8—, —NR8C(═O)—, —NR8C(═O)CH2O—, —NR8C(═O)—CH(CH3)O—, —NR8C(═O)—C(CH3)2O—, —N(R8)S(═O)2—, —S(═O)2N(R8)—, —C(═O)—, —OC(═O)—, —C(═O)O—, —OC(═O)O—, —OC(═O)N(R8)—, —NR8C(═O)O—, or —NR8C(═O)N(R8)—; provided that when L4 is absent then X1 is not —NR8C(═O)O—; R5 is H, or C1-C4alkyl; R7 is H, —S(═O)2R10, —S(═O)2N(R9)2, —C(═O)R10, —CO2R9, —C(═O)N(R9)2, C1-C4alkyl, C1-C4fluoroalkyl, or C1-C4heteroalkyl; R8 is H, C1-C4alkyl, or C1-C4fluoroalkyl; L5 is absent or a substituted or unsubstituted C1-C4alkylene, where if L5 is substituted then L5 is substituted with 1, 2, or 3 R15; each R15 is independently selected from F, C1-C4alkyl, C1-C4fluoroalkyl, hydroxyl, C1-C4alkoxy, and C1-C4fluoroalkoxy; R6 is C1-C6alkyl, C1-C6fluoroalkyl, substituted or unsubstituted C3-C10cycloalkyl, a substituted or unsubstituted C3-C10heterocycloalkyl, a substituted or unsubstituted phenyl, a substituted or unsubstituted naphthyl, a substituted or unsubstituted monocyclic heteroaryl, or a substituted or unsubstituted bicyclic heteroaryl, wherein if R6 is substituted then R6 is substituted with 1, 2 or 3 RC; RC is independently selected from halogen, —CN, —NO2, —OH, —OR9, —SR9, —S(═O)R10, —S(═O)2R10, —N(R9)S(═O)2R10, —S(═O)2N(R9)2, —C(═O)R10, —OC(═O)R10, —CO2R9, —OCO2R10, —N(R9)2, —C(═O)N(R9)2, —OC(═O)N(R9)2, —NR9C(═O)N(R9)2, —NR9C(═O)R10, —NR9C(═O)OR10, C1-C4alkyl, C1-C4fluoroalkyl, C1-C4fluoroalkoxy, C1-C4alkoxy, and C1-C4heteroalkyl; each of RA and RB independently, are selected from halogen, —CN, —OH, C1-C4alkyl, C1-C4fluoroalkyl, C1-C4fluoroalkoxy, C1-C4alkoxy, and C1-C4heteroalkyl; each R9 is independently selected from H, C1-C12alkyl, C1-C6heteroalkyl, C1-C6fluoroalkyl, a substituted or unsubstituted C3-C6cycloalkyl, a substituted or unsubstituted C2-C6heterocycloalkyl, a substituted or unsubstituted phenyl, a substituted or unsubstituted monocyclic heteroaryl, —C1-C4alkylene-(substituted or unsubstituted C3-C6cycloalkyl), —C1-C4alkylene-(substituted or unsubstituted C2-C6heterocycloalkyl), —C1-C4alkylene-(substituted or unsubstituted phenyl), or —C1-C4alkylene-(substituted or unsubstituted heteroaryl); or two R9 groups attached to the same N atom are taken together with the N atom to which they are attached to form a substituted or unsubstituted heterocycle; R10 is selected from C1-C6alkyl, C1-C6heteroalkyl, C1-C6fluoroalkyl, a substituted or unsubstituted C3-C6cycloalkyl, a substituted or unsubstituted C2-C6heterocycloalkyl, a substituted or unsubstituted phenyl, a substituted or unsubstituted naphthyl, a substituted or unsubstituted monocyclic heteroaryl, —C1-C4alkylene-(substituted or unsubstituted C3-C6cycloalkyl), —C1-C4alkylene-(substituted or unsubstituted C2-C6heterocycloalkyl), —C1-C4alkylene-(substituted or unsubstituted phenyl), and —C1—C alkylene-(substituted or unsubstituted heteroaryl).
地址 Princeton NJ US